Results 251 to 260 of about 1,830,783 (287)

Repurposed Drugs

Journal of Prescribing Practice
In this month's article, George Winter discusses the potential for repurposed drugs to change the therapeutic landscape
Duilio Cervantes, Aida Adlimoghaddam
openaire   +2 more sources

Purposeful Drug Repurposing

JAMA Psychiatry
This Viewpoint discusses a proposal to identify candidates for drug repurposing and allocate US Food and Drug Administration funds to cover the cost of evaluating and approving such drugs for their novel indications.
Peter, Nagele, Charles R, Conway, Charles F, Zorumski   +2 more
openaire   +2 more sources

Drug repurposing for cancer

In the dynamic landscape of cancer therapeutics, the innovative strategy of drug repurposing emerges as a transformative paradigm, heralding a new era in the fight against malignancies. This book chapter aims to embark on the comprehension of the strategic deployment of approved drugs for repurposing and the meticulous journey of drug repurposing from ...
Juni, Banerjee, Anand Krishna, Tiwari, Shuvomoy, Banerjee   +2 more
openaire   +2 more sources

repurposing drugs

2023
This data set examines the practice of repurposing drugs for multiple therapeutic purposes, which is a persistent 'innovation' strategy in the pharmaceutical industry.
openaire   +1 more source

Computational Methods for Drug Repurposing

2022
The wealth of knowledge and multi-omics data available in drug research has allowed the rise of several computational methods in the drug discovery field, resulting in a novel and exciting strategy called drug repurposing. Drug repurposing consists in finding new applications for existing drugs.
Rapicavoli, Rosaria Valentina, Alaimo, Salvatore, Ferro, Alfredo, Pulvirenti, Alfredo   +3 more
openaire   +2 more sources

An overview to drug repurposing

Identification and implementation of novel drug are not only time consuming and expensive but also it poses huge challenge to reach into the market. Currently, thousands of USFDA approved drugs licence are being expired that can be repurposed for treating other diseases.
Khushal, Khambhati, Abdulrahman H, Alessa, Vijai, Singh   +2 more
openaire   +2 more sources

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules [PDF]

Pharmaceuticals, 2018
Schistosomiasis is a major neglected tropical disease. Control of schistosomiasis currently relies on a single drug, praziquantel, and despite its efficacy against the all schistosome species that parasitize humans, it displays some problematic drawbacks and alone is ineffective in counteracting adverse pathologies associated with infection.
Nuno Vale, José M Costa, Gärtner F
exaly   +5 more sources

Drug Repurposing Based on Drug–Drug Interaction

Chemical Biology & Drug Design, 2014
Given the high risk and lengthy procedure of traditional drug development, drug repurposing is gaining more and more attention. Although many types of drug information have been used to repurpose drugs, drug–drug interaction data, which imply possible physiological effects or targets of drugs, remain unexploited.
Bin, Zhou, Rong, Wang, Ping, Wu, De-Xin, Kong   +3 more
openaire   +2 more sources

Drug repurposing in oncology

The Lancet Oncology, 2020
Frantzi, Maria, Latosinska, Agnieszka, Mokou, Marika, Mischak, Harald, Vlahou, Antonia   +4 more
openaire   +4 more sources

Drug repurposing in kidney disease

Kidney International, 2018
Drug repurposing, is the re-tasking of known medications for new clinical indications. Advantages, compared to de novo drug development, include reduced cost and time to market plus the added benefit of a known pharmacokinetic and safety profiles. Suitable drug candidates are identified through serendipitous observations, data mining, or increased ...
Usha, Panchapakesan, Carol, Pollock
openaire   +2 more sources